Search

SMS Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 41.60 -0.35  | -0.83% -37.82% 8.63 351.31
NSE Price: Oct 18, 15:46 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:46 41.60 -0.35 -0.83% 42.60 41.95 18,645 41.10 - 43.50
BSE Oct 18, 2019 41.50 -0.10 -0.24% 42.50 41.60 9,429 40.45 - 42.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 36,426 P/B: 1.01 NSE Code: SMSPHARMA
52-Week Range: R 39.80 - 81.90 Dividend Yield: 0.60% BSE Code: 532815
TTM EPS: R 4.81 Book Value: R 41.28 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
SMS Pharmaceuticals -38.52 -12.45 -10.46 -37.65 -26.24 -3.41 10.28
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -0.00 -8.73 -2.39
Net Profit 2.47 -0.15 15.25
EPS 2.47 -0.15 15.25
Book Value 12.89 4.91 8.91
Average
Operating Margin 20.12 19.30 18.11
Net Margin 8.85 8.49 7.62
Return on Networth 12.93 13.36 14.01
Return on Investment 15.96 15.41 16.65
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - -6.37 -
Operating Profit - -0.04 -
Net Profit - -6.26 -
EPS - 8.36 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
SMS Pharmaceuticals 351.31 456.94 40.71 8.84 13.67 1.01 8.63
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 11, 2019 Sukumari Koneru  Sell Gift 20,000 46.80 9.36
Sep 11, 2019 Sukumari Koneru  Sell Gift 20,000 46.80 9.36
Sep 11, 2019 Vamsi Krishna Potluri  Buy Gift 20,000 46.80 9.36
Sep 11, 2019 Vamsi Krishna Potluri  Buy Gift 20,000 46.80 9.36
Jun 28, 2017 Potluri Infra Projects LLP  Buy Market 1,300,000 73.85 960.05
Fund Houses invested in the stock
Fund Jun-16 Mar-16 Dec-15 Sep-15 Jun-15
Nippon India Mutual Fund 0.211 0.211 0.527 0.420 -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: SMS Pharmaceuticals Ltd.

Address: Plot No. 72, H.no. 8-2-334 / 3 & 4,, Road No. 5, Opp. Sbi Executive Enclave, Banjara Hills, Hyderabad, Telangana - 500034 | Phone: 040 2525 9999 | Fax: 040 2525 9889

Email: [email protected]

Website: www.smspharma.com

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285 , Domalaguda,,Hyderabad, 1-2-285, Domalaguda | Phone: 040-7642217/7634445 | Fax: 040-7632184

Essential checks
Altman Z-Score
2.96
Piotroski F-Score
6
Modified C-Score
2
5-Years Price to Earnings
8.63
5-Years Price to Book
1.01
Earnings Yield
EBIT / Enterprise value
15.33%
PEG
Price / Earnings to growth ratio
1.91
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59